GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $932,000 | -1.0% | 21,416 | -0.9% | 0.10% | +15.9% |
| Q1 2022 | $941,000 | -0.2% | 21,601 | +1.0% | 0.08% | 0.0% |
| Q4 2021 | $943,000 | +14.0% | 21,383 | -1.3% | 0.08% | +9.3% |
| Q3 2021 | $827,000 | -4.1% | 21,655 | +0.0% | 0.08% | -1.3% |
| Q2 2021 | $862,000 | +4.4% | 21,647 | -6.5% | 0.08% | -3.8% |
| Q1 2021 | $826,000 | -2.9% | 23,155 | +0.1% | 0.08% | -11.2% |
| Q4 2020 | $851,000 | -2.4% | 23,125 | -0.2% | 0.09% | -16.8% |
| Q3 2020 | $872,000 | -7.3% | 23,167 | +0.4% | 0.11% | -23.6% |
| Q2 2020 | $941,000 | +267.6% | 23,070 | +265.3% | 0.14% | +418.5% |
| Q3 2017 | $256,000 | +10.3% | 6,315 | +17.2% | 0.03% | +3.8% |
| Q2 2017 | $232,000 | +1.3% | 5,389 | -0.7% | 0.03% | 0.0% |
| Q1 2017 | $229,000 | +90.8% | 5,429 | +74.0% | 0.03% | +225.0% |
| Q3 2015 | $120,000 | – | 3,121 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |